Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: ATEV Primary Patency - Extremity Group (Non-iatrogenic) Measure: Rate of ATEV Infection - Extremity Group (Non-iatrogenic) Measure: Number of Participants With Adverse Events for Each Severity Grade - Extremity Group (Non-iatrogenic). After: Measure: Primary Patency Rate of the Human Acellular Vessel (HAV) at Day 30 in the All HAV Group Measure: Primary Patency Rate of the Human Acellular Vessel (HAV) at Day 30 in the Extremity Community-Acquired Trauma Subgroup.
Actual enrollment increased by 21 participants
Before: 51 participants (actual). After: 72 participants (actual).
Primary completion date changed
Before: 30 Jun 2023. After: 19 Sep 2023.
Recruitment status changed
Before: Active not recruiting. After: Completed.